1. Home
  2. ELVN vs OUST Comparison

ELVN vs OUST Comparison

Compare ELVN & OUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • OUST
  • Stock Information
  • Founded
  • ELVN 2016
  • OUST 2015
  • Country
  • ELVN United States
  • OUST United States
  • Employees
  • ELVN N/A
  • OUST N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • OUST Industrial Machinery/Components
  • Sector
  • ELVN Health Care
  • OUST Technology
  • Exchange
  • ELVN Nasdaq
  • OUST Nasdaq
  • Market Cap
  • ELVN 1.2B
  • OUST 1.1B
  • IPO Year
  • ELVN 2020
  • OUST N/A
  • Fundamental
  • Price
  • ELVN $19.32
  • OUST $22.49
  • Analyst Decision
  • ELVN Strong Buy
  • OUST Strong Buy
  • Analyst Count
  • ELVN 5
  • OUST 7
  • Target Price
  • ELVN $41.20
  • OUST $17.33
  • AVG Volume (30 Days)
  • ELVN 410.5K
  • OUST 2.9M
  • Earning Date
  • ELVN 08-12-2025
  • OUST 08-07-2025
  • Dividend Yield
  • ELVN N/A
  • OUST N/A
  • EPS Growth
  • ELVN N/A
  • OUST N/A
  • EPS
  • ELVN N/A
  • OUST N/A
  • Revenue
  • ELVN N/A
  • OUST $117,789,000.00
  • Revenue This Year
  • ELVN N/A
  • OUST $32.34
  • Revenue Next Year
  • ELVN N/A
  • OUST $36.11
  • P/E Ratio
  • ELVN N/A
  • OUST N/A
  • Revenue Growth
  • ELVN N/A
  • OUST 28.04
  • 52 Week Low
  • ELVN $13.30
  • OUST $5.84
  • 52 Week High
  • ELVN $30.03
  • OUST $31.77
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 40.65
  • OUST 44.72
  • Support Level
  • ELVN $21.25
  • OUST $25.05
  • Resistance Level
  • ELVN $22.83
  • OUST $28.73
  • Average True Range (ATR)
  • ELVN 1.42
  • OUST 2.38
  • MACD
  • ELVN -0.35
  • OUST -0.90
  • Stochastic Oscillator
  • ELVN 5.60
  • OUST 4.33

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About OUST Ouster Inc.

Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.

Share on Social Networks: